Update on morphea

Part I. Epidemiology, clinical presentation, and pathogenesis

Nicole Fett, Victoria P. Werth

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

Morphea, also known as localized scleroderma, is a rare fibrosing disorder of the skin and underlying tissues. Morphea is differentiated from systemic sclerosis based on the absence of sclerodactyly, Raynaud phenomenon, and nailfold capillary changes. Patients with morphea commonly have systemic symptoms, such as malaise, fatigue, arthralgias, and myalgias, as well as positive autoantibody serologies. However, involvement of morphea is almost uniformly limited to those tissues derived from the mesoderm. The underlying pathogenesis of morphea is incompletely understood at this time, but ultimately results in an imbalance of collagen production and destruction.

Original languageEnglish (US)
Pages (from-to)217-228
Number of pages12
JournalJournal of the American Academy of Dermatology
Volume64
Issue number2
DOIs
StatePublished - Feb 2011
Externally publishedYes

Fingerprint

Localized Scleroderma
Epidemiology
Raynaud Disease
Systemic Scleroderma
Myalgia
Arthralgia
Mesoderm
Serology
Autoantibodies
Fatigue
Collagen
Skin

Keywords

  • autoimmune connective tissue disorder
  • fibrosing disorders
  • localized scleroderma
  • morphea
  • scleroderma
  • systemic sclerosis

ASJC Scopus subject areas

  • Dermatology

Cite this

Update on morphea : Part I. Epidemiology, clinical presentation, and pathogenesis. / Fett, Nicole; Werth, Victoria P.

In: Journal of the American Academy of Dermatology, Vol. 64, No. 2, 02.2011, p. 217-228.

Research output: Contribution to journalArticle

@article{f2f48c4b9be14b04b87c9578ccff6f83,
title = "Update on morphea: Part I. Epidemiology, clinical presentation, and pathogenesis",
abstract = "Morphea, also known as localized scleroderma, is a rare fibrosing disorder of the skin and underlying tissues. Morphea is differentiated from systemic sclerosis based on the absence of sclerodactyly, Raynaud phenomenon, and nailfold capillary changes. Patients with morphea commonly have systemic symptoms, such as malaise, fatigue, arthralgias, and myalgias, as well as positive autoantibody serologies. However, involvement of morphea is almost uniformly limited to those tissues derived from the mesoderm. The underlying pathogenesis of morphea is incompletely understood at this time, but ultimately results in an imbalance of collagen production and destruction.",
keywords = "autoimmune connective tissue disorder, fibrosing disorders, localized scleroderma, morphea, scleroderma, systemic sclerosis",
author = "Nicole Fett and Werth, {Victoria P.}",
year = "2011",
month = "2",
doi = "10.1016/j.jaad.2010.05.045",
language = "English (US)",
volume = "64",
pages = "217--228",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Update on morphea

T2 - Part I. Epidemiology, clinical presentation, and pathogenesis

AU - Fett, Nicole

AU - Werth, Victoria P.

PY - 2011/2

Y1 - 2011/2

N2 - Morphea, also known as localized scleroderma, is a rare fibrosing disorder of the skin and underlying tissues. Morphea is differentiated from systemic sclerosis based on the absence of sclerodactyly, Raynaud phenomenon, and nailfold capillary changes. Patients with morphea commonly have systemic symptoms, such as malaise, fatigue, arthralgias, and myalgias, as well as positive autoantibody serologies. However, involvement of morphea is almost uniformly limited to those tissues derived from the mesoderm. The underlying pathogenesis of morphea is incompletely understood at this time, but ultimately results in an imbalance of collagen production and destruction.

AB - Morphea, also known as localized scleroderma, is a rare fibrosing disorder of the skin and underlying tissues. Morphea is differentiated from systemic sclerosis based on the absence of sclerodactyly, Raynaud phenomenon, and nailfold capillary changes. Patients with morphea commonly have systemic symptoms, such as malaise, fatigue, arthralgias, and myalgias, as well as positive autoantibody serologies. However, involvement of morphea is almost uniformly limited to those tissues derived from the mesoderm. The underlying pathogenesis of morphea is incompletely understood at this time, but ultimately results in an imbalance of collagen production and destruction.

KW - autoimmune connective tissue disorder

KW - fibrosing disorders

KW - localized scleroderma

KW - morphea

KW - scleroderma

KW - systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=78751561101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751561101&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2010.05.045

DO - 10.1016/j.jaad.2010.05.045

M3 - Article

VL - 64

SP - 217

EP - 228

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2

ER -